Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 273 | 0 | 18 | 87 | 172 |
Gross Profit | 273 | N/A | 18 | 87 | 172 |
Operating Expenses | 26,002 | 24,085 | 33,579 | 26,921 | 32,034 |
Operating Income | -25,729 | -24,085 | -33,561 | -26,834 | -31,862 |
Interest Expense | 702 | 687 | 690 | 686 | 658 |
Other Income | -30,919 | -2,610 | 15,538 | 71,129 | -1,066 |
Pre-tax Income | -57,350 | -27,382 | -18,713 | 43,609 | -33,586 |
Income Tax | 19 | -4 | 428 | 238 | 185 |
Net Income Continuous | -57,369 | -27,378 | -19,141 | 43,371 | -33,771 |
Minority Interests | -57 | -665 | -850 | -873 | -729 |
Net Income | $-57,312 | $-26,713 | $-18,291 | $44,244 | $-33,042 |
EPS Basic Total Ops | -0.36 | -0.17 | -0.11 | 0.28 | -0.21 |
EPS Basic Continuous Ops | -0.36 | -0.17 | -0.12 | 0.28 | -0.22 |
EPS Diluted Total Ops | -0.36 | -0.17 | -0.08 | 0.25 | -0.21 |
EPS Diluted Continuous Ops | -0.36 | -0.17 | -0.08 | 0.24 | -0.22 |
EPS Diluted Before Non-Recurring Items | -0.36 | -0.17 | -0.12 | -0.14 | -0.21 |
EBITDA(a) | $-25,647 | $-24,002 | $-33,460 | $-26,760 | $-31,783 |